Skip to main content
logo
NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.920
+0.050 (1.74%)
At close: Sep 29, 2026, 4:00 PM EDT
2.939
+0.019 (0.66%)
Pre-market: Sep 30, 2026, 5:11 AM EDT

NRx Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
12680273875281
Market Cap Growth
117.43%202.37%-30.71%-48.99%-73.29%328.57%
Enterprise Value
10083313957243
Last Close Price
2.922.712.204.6011.1047.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-39.16----
PS Ratio
37.2265.49----
PB Ratio
--5.03-1.14-3.2610.1313.51
P/TBV Ratio
----10.1313.51

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
29.6068.00----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-4.91-0.04-0.27-0.781.420.03
Net Debt / Equity Ratio
152.070.45-0.21-0.39-1.29-1.30
Net Debt / EBITDA Ratio
1.310.45-0.24-0.170.220.29
Net Debt / FCF Ratio
1.250.51-0.45-0.210.240.72
Asset Turnover
0.170.15----
Quick Ratio
0.790.280.070.241.292.32
Current Ratio
0.860.310.150.361.662.74
Return on Equity (ROE)
-----281.79%-
Return on Assets (ROA)
-63.99%-121.85%-224.60%-104.08%-94.66%-330.91%
Return on Capital Employed (ROCE)
-6980.40%103.60%108.20%235.10%-433.30%-453.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-18.59%-35.68%-94.69%-78.73%-52.95%-33.11%
FCF Yield
-16.36%-17.59%-40.09%-56.56%-52.96%-13.41%
Buyback Yield / Dilution
-110.42%-101.06%-40.50%-15.20%-40.17%-36.90%
SEC Filings: 10-K · 10-Q